244
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitroin vivo correlation

, , , , &
Pages 1305-1312 | Received 31 Mar 2011, Accepted 14 Dec 2011, Published online: 01 Feb 2012

References

  • Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
  • Oh Doo-Man Curl, RL, Amidon GL. (1993). Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm Res, 10:264–270.
  • Kobayashi M, Sada N, Sugawara M, Iseki K, Miyazaki K. (2001). Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. Int J Pharm, 221:87–94.
  • He X, Sugawara M, Kobayashi M, Takekuma Y, Miyazaki K. (2003). An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs. Int J Pharm, 263:35–44.
  • He X, Kadomura S, Takekuma Y, Sugawara M, Miyazaki K. (2004a). A new system for the prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption. J Pharm Sci, 93:71–77.
  • He X, Sugawara M, Takekuma Y, Miyazaki K. (2004b). Absorption of ester prodrugs in Caco-2 and rat intestine models. Antimicrob Agents Chemother, 48:2604–2609.
  • Zheng HZ, Dong ZH, She Q. (1998). Modern research and application of traditional Chinese Medicine. Beijing, China: Xueyan Press.
  • Yuan YF, Liu ZL, Li XL. (1996). Use of silica gel with reversed-phase eluents for the separation and determination of alkaloids in Corydalis Yanhusuo W. T. Wang and its preparations. Biomed Chromatogr, 10:11–14.
  • Lin MT, Chueh FY, Hsieh MT, Chen CF. (1996). Antihypertensive effects of DL-tetrahydropalmatine: an active principle isolated from Corydalis. Clin Exp Pharmacol Physiol, 23:738–742.
  • Li ZQ, He X, Gao X, Xu YY, Wang YF, Gu H et al. (2011). Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: level A in vitro–in vivo correlation. Eur J Pharm Biopharm, 79:364–371.
  • Wagner JG, Nelson E. (1963). Per cent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci, 52:610–611.
  • Dou ZY, Sun W, Mi XL, Yao LP. (2007). Comparison of pharmacokinetics of tetrahydropalmatine monomer and extractive of corydalis and corydalis processed with vinegar. Zhong Yao Cai, 30:1499–1501.
  • National committee of pharmacopoeia. (2010). Pharmacopoeia of the People’s Republic of China, vol 1. Beijing, China: Chemical Industry Publishing House.
  • Löbenberg R, Amidon GL. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm, 50:3–12.
  • Food and Drug Administration. (2000). Guidance for Industry: Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville.
  • Sugawara M, Kadomura S, He X, Takekuma Y, Kohri N, Miyazaki K. (2005). The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations. Eur J Pharm Sci, 26:1–8.
  • Deng Y, Liao Q, Li S, Bi K, Pan B, Xie Z. (2008). Simultaneous determination of berberine, palmatine and jatrorrhizine by liquid chromatography-tandem mass spectrometry in rat plasma and its application in a pharmacokinetic study after oral administration of coptis-evodia herb couple. J Chromatogr B Analyt Technol Biomed Life Sci, 863:195–205.
  • Liu XF, Wu XA, Luo JY. (2007). The absorption kinetics study of ferulic acid in rat after oral administration of ferulic acid and chuanxiong decoction. J Chin Med Mater, 30:831–833.
  • Food and Drug Administration. (1997). Guidance for Industry: Extended Release Oral Dosage Forms: Development, evaluation, and application of in vitro/in vivo correlations. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville.
  • Mu X, Tobyn MJ, Staniforth JN. (2003). Development and evaluation of bio-dissolution systems capable of detecting the food effect on a polysaccharide-based matrix system. J Control Release, 93:309–318.
  • Varshosaz J, Ghafghazi T, Raisi A, Falamarzian M. (2000). Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies. Eur J Pharm Biopharm, 50:301–306.
  • Philip AK, Pathak K. (2008). Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug. Drug Dev Ind Pharm, 34:735–743.
  • Rostami-Hodjegan A, Shiran MR, Tucker GT, Conway BR, Irwin WJ, Shaw LR et al. (2002). A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev Ind Pharm, 28:533–543.
  • Siddique S, Bose A, Khanam J. (2011). Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix. Drug Dev Ind Pharm, 37:1016–1025.
  • Modi NB. (2007). In vitro–in vivo correlation. In: Chilukuri DM, Sunkara G, Young D, ed. Pharmaceutical Product Development in vitro–in vivo Correlation. New York: Informa Healthcare, 107–123.
  • Souliman S, Beyssac E, Cardot JM, Denis S, Alric M. (2007). Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system. Drug Dev Ind Pharm, 33:475–483.
  • Emara LH, el-Menshawi BS, Estefan MY. (2000). In vitro–in vivo correlation and comparative bioavailablity of vincamine in prolonged-release preparations. Drug Dev Ind Pharm, 26:243–251.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.